End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- CAD | -.--% | -.--% | -.--% |
2023 | Haemonetics Completes $255 Million Acquisition of OpSens | MT |
2023 | OpSens Brief: NYSE's Haemonetics Completed Acquisition | MT |
Business Summary
Number of employees: 293
Managers
Managers | Title | Age | Since |
---|---|---|---|
Louis Laflamme
CEO | Chief Executive Officer | - | - |
John Hannigan
DFI | Director of Finance/CFO | - | 23-03-26 |
Gaétan Duplain
BRD | Director/Board Member | - | 06-09-30 |
Pierre Poulin
AUD | Comptroller/Controller/Auditor | - | 12-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Alan Milinazzo
CHM | Chairman | 64 | 19-03-03 |
Jean Lavigueur
BRD | Director/Board Member | 63 | 12-01-15 |
Denis Harrington
BRD | Director/Board Member | - | 15-01-19 |
Gaétan Duplain
BRD | Director/Board Member | - | 06-09-30 |
Denis Sirois
BRD | Director/Board Member | 53 | 06-02-28 |
James Mackin
BRD | Director/Board Member | 57 | 16-09-06 |
Louis Laflamme
CEO | Chief Executive Officer | - | - |
Lori Chmura
BRD | Director/Board Member | - | 21-09-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 115,453,608 | 115,067,451 ( 99.67 %) | 0 | 99.67 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+9.24% | 221B | |
+15.84% | 198B | |
+23.95% | 148B | |
+31.67% | 112B | |
+4.68% | 66.85B | |
+14.99% | 52.84B | |
+4.85% | 50.86B | |
-4.47% | 38.75B | |
-0.41% | 35.15B |
- Stock Market
- Equities
- OPS Stock
- Stock
- Company Opsens Inc.